Genosvid Diagnostic Test for Early Detection of COVID-19

NACompletedINTERVENTIONAL
Enrollment

1,999

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

December 12, 2020

Study Completion Date

December 12, 2020

Conditions
COVID-19
Interventions
OTHER

exhaled breath sampling

The participants breath through non-rebreathing mask until the reservoir bag is full. The reservoir bag is connected to Hepa-filter at one side, and another side of Hepa-filter is connected to the electronic-nose (Genosvid) device.

OTHER

exhaled breath sampling

The participants breath through non-rebreathing mask until the reservoir bag is full. The reservoir bag is connected to Hepa-filter at one side, and another side of Hepa-filter is connected to the electronic-nose (Genosvid) device.

OTHER

exhaled breath sampling

The participants breath normally using a mask for 2 times then they are asked to inhale and exhale in a forced expiratory volume through an e-nose tube connected to the Hepa-filter at the inlet.

Trial Locations (8)

55281

Dr Sardjito Hospital, Yogyakarta

55764

Bambanglipuro Hospital, Yogyakarta

Unknown

RS Bhayangkara Tk I R.Said Soekanto, Jakarta

Saiful Anwar, Malang

Bhayangkara Tk III Polda DIY, Yogyakarta

RS Akademik UGM, Yogyakarta

RSPAU Hardjolukito, Yogyakarta

RST Tk III Dr Soetarto, Yogyakarta

All Listed Sponsors
lead

Gadjah Mada University

OTHER

NCT04558372 - Genosvid Diagnostic Test for Early Detection of COVID-19 | Biotech Hunter | Biotech Hunter